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Glomerular protein sieving and implications for renal failure Although the sieving of plasma proteins by the glomer-
in Fanconi syndrome. ulus has been widely studied in animal models, little is
Background. Glomerular sieving coefficients (GSCs) of pro- known of the process in humans [1, 2]. The Fanconiteins have been measured extensively in animals but not humans.
syndrome, which includes a “knock-out” of renal tubularWe have studied the proteinuria of Fanconi syndrome, a “knock-
protein reabsorption causing “tubular” proteinuria, pre-out” of renal tubular protein reabsorption, to estimate GSCs
and detect potential contributors to development of renal failure. sents an opportunity for the estimation of the glomerular
Methods. Immunoassay of proteins and polypeptides in se- sieving coefficients (GSCs) of endogenous plasma pro-
rum and urine of patients with early Dent’s disease (mean teins in humans. We also have investigated why the tubularGFR  83 mL/min, range 60 to 101, N  5), Lowe’s syndrome
proteinuria of the Fanconi syndrome consistently includes(N  3), and ADIF (N  2) were used.
high concentrations of albumin, 65 kD and 2-glycopro-Results. Twenty-one proteins, ranging in mass from insulin
(5.1 kD) and parathyroid hormone (PTH; 9.4 kD) to transferrin tein-I (2GI), 50 kD which sometimes exceed those of
(78 kD) and intact IgG (160 kD), were present in Fanconi low-molecular-weight (LMW) proteins such as 2-micro-
urine at 6 to 1000-fold normal. A simple model assuming globulin (2m), 11.6 kD and retinol-binding proteincomplete “knock-out” of the reuptake of each protein filtered
(RBP), 21 kD [3–5]. In addition, we searched for proteinsnormally by the glomerulus was applied to protein excretion by
excreted in the urine of patients with the Fanconi syn-Dent’s patients. GSCs were estimated for 12 plasma proteins,
including albumin (7.7  0.9  105) and IgG (4.2  0.28  drome that may be bioactive within the renal tubule and
105; mean  SEM). We calculated the albumin concentration contribute to the progressive renal impairment com-
in normal glomerular filtrate to be 3.5  0.41 mg/L (53  6.4 monly found in this disease [6, 7].nmol/L), consistent with studies in rat and dog.
The renal Fanconi syndrome (Lignac-de Toni-Debre´-Conclusions. To our knowledge, this study provides the first
Fanconi syndrome) consists of a generalized dysfunctionestimates of human in vivo GSCs. Our model explains why
tubular proteinuria of Fanconi syndrome includes proteins of of the proximal renal tubule with—in its full form—
mass of albumin and above as well as low-molecular-weight impaired proximal reabsorption of protein, amino acids,
proteins, and further characterizes the endocytic pathway(s) glucose, phosphate, urate and bicarbonate and rickets/believed defective in these syndromes. High urinary concentra-
osteomalacia [6, 8]. Dent’s disease (CLCN5 mutation),tions of potentially bioactive hormones such as PTH, insulin,
the oculocerebrorenal syndrome of Lowe (OCRL muta-IGF-1 and the chemokine monocyte chemoattractant protein-1
(MCP-1), were found; their presence in tubular fluid may con- tion) and autosomal-dominant idiopathic Fanconi syn-
tribute to the hypercalciuria, interstitial fibrosis, and the pro- drome (ADIF) are examples of inherited renal Fanconi
gressive renal failure of Fanconi syndromes. syndromes. Although other features of the Fanconi syn-
drome vary in these disorders, there is a consistent defect
of renal tubular protein reabsorption, a process largelyKey words: hypercalciuria, tubular proteinuria, Dent’s disease, Lowe’s
syndrome, interstitial fibrosis, progressive renal failure, albumin, pro- localized to the proximal tubule [3, 6], and this defect
tein reabsorption. causes tubular proteinuria.
Dent’s disease is an X-linked disorder that presentsReceived for publication April 24, 2001
Accepted for publication June 19, 2001 clinically as nephrocalcinosis, nephrolithiasis, and even-
tual renal failure in affected males; females are usually 2001 by the International Society of Nephrology
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clinically unaffected or have a milder disorder [9–11]. tubular proteinuria typical of the disease, and a creati-
nine clearance 60 mL/min. Creatinine clearance wasThe molecular basis of the disease is a defective CLC-5
chloride ion channel encoded by CLCN5 [12–14]. In either measured from a 24-hour collection of urine or
calculated on the basis of serum creatinine, age, andLowe’s syndrome, also an X-linked disorder, there is men-
tal retardation, visual impairment, and chronic progressive weight [19]. A further three patients with a clinical, labo-
ratory, and molecular genetic diagnosis of Dent’s disease,renal impairment [15]; nephrocalcinosis also may be found
in this disease [16]. The underlying defect in Lowe’s syn- but with creatinine clearances 45 mL/min, were also
studied. The three patients with Lowe’s syndrome havedrome is deficiency of phosphatidylinositol 4,5 bisphos-
phate 5-phosphatase due to mutation of OCRL. Patients severe mental and growth retardation, visual impair-
ment, and tubular proteinuria; two of the patients arewith ADIF, for which the molecular basis is currently
unknown, manifest progressive renal impairment and brothers. The two patients with ADIF are father and
son in a family described previously [7]. Creatinine clear-nephrocalcinosis [7].
Tubular proteinuria, usually described as a predomi- ances of patients studied are given in Table 1.
nantly LMW proteinuria, is found in the renal Fanconi
Specimen collectionsyndrome [3, 6]. It is the most consistent laboratory find-
ing among families affected by Dent’s disease [11]. This Midstream random specimens of urine following at
least 18 hours of sexual inactivity were refrigerated im-proteinuria is believed to be due to a failure of endocyto-
sis by the proximal tubule of proteins filtered by the mediately, frozen within four hours at 80C for up to
two days, and transferred to liquid nitrogen for up toglomerulus [13, 14]. Tubular proteinuria is present at an
early age in Dent’s disease and may be present at birth. one year before analysis. Serum specimens were ob-
tained from two of the five patients with Dent’s diseaseIt precedes significant renal glomerular failure by some
10 to 20 years [9]. How the ion-channel defect in Dent’s and stored in the same way.
disease and the phosphatidylinositol phosphatase defi-
Immunoassaysciency in Lowe’s syndrome cause tubular proteinuria and
eventual renal failure in these disorders is unclear. In The following methods were used for measurement
of proteins and polypeptides in urine and serum (abbre-Dent’s disease, a defect in normal trafficking of the giant
proximal tubular endocytic receptor megalin has recently viations as in Table 1): 2m, IMx analyzer (Abbott Diag-
nostics, Maidenhead, UK); RBP, [20]; TSH, FSH and LHbeen proposed (abstract; Norden, J Am Soc Nephrol
11:93A, 2000) [13, 14]. AxSym analyzer (Abbott Diagnostics); 	1m, TTR and
albumin, Array analyzer (Beckman Coulter, High Wy-Our findings show that the proteinuria of the Fanconi
syndrome is more generalized than previously suspected. combe, UK); kappa and lambda immunoglobulin light
chains, 	1AG, DBP and ZAG, radial immunodiffusionWe present a unifying quantitative explanation for this,
based on plasma concentrations and predominantly size- [21] using antibody from Dade-Behring (Milton Keynes,
UK); 2GI, [20]; TRF, BNII analyzer Dade-Behringselective glomerular filtration, and offer the first esti-
mates of human in vivo glomerular sieving coefficients (Milton Keynes, UK); SHBG and GH, Immulite ana-
lyzer (DPC Corp., Los Angeles, CA, USA); IgG, modi-for 12 plasma proteins. We also have found high concen-
trations of polypeptides, including hormones and a che- fication of immunoassay for 2GI with use of anti-IgG
antibodies supplied by Dako (Ely, UK) and purified uri-mokine in urine from these patients, and speculate that
tubular bioactivity of these peptides may play a role nary IgG calibrant from Scipac (Sittingbourne, UK);
IGF-1 and PTH (intact), Advantage analyzer (Nichollsin the pathogenesis of progressive renal failure in the
Fanconi syndrome. Institute, Newport, UK); MCP-1 (ELISA using matched
antibody pair, R&D Systems, Abingdon, UK); insulin
was measured on both the Access (Beckman, High Wy-
METHODS
combe, UK) and DELFIA (Perkin-Elmer, Beacons-
Patients field, UK) analyzers. Results of protein and hormone
excretion are expressed per mmol creatinine determinedClinical, laboratory, and molecular genetic features of
the five affected male patients with Dent’s disease whom by a kinetic Jaffe´ method.
we studied in detail have been described; these patients
Immunoblottinghad relatively well-preserved creatinine clearances (Ta-
ble 1): Patients C/II/2, total CLCN5 deletion and F/II/1, To confirm the presence of intact IgG, urine samples
were diluted in 62.5 mmol/L Tris chloride buffer, pHW279X [9, 12]; a member of family 7.1/94, splice-site
mutation with deletion of codons 132-241 [12] and cases 6.8, and denatured by adding an equal volume of 10%
sodium dodecyl sulfate (SDS), 20% glycerol, 0.003%4/96, R34X [17] and 6/97, 1175-1176delGT; 346 amino
acid deletion [18]. Each patient has a mutation in CLCN5 bromophenol blue in the same buffer and heating at 40C
for 30 minutes. After electrophoresis on nonreducing 4associated with loss of function of the chloride channel,
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Table 1. Estimated glomerular sieving coefficients (GSCs) of proteins and protein excretion by patients with Dent’s disease, Lowe’s syndrome
and autosomal-dominant idiopathic Fanconi syndrome (ADIF)
Urinary excretiona mg/mmol creatinine
Molecular GSC estimated Normal
weight from Dent’s Dent’s Lowe’s ADIF Normal plasma levelsa
Protein Abbv. kD patients N  5 N  3 N  2 N  8 mg/Lb
2-microglobulin 2m 11.6 0.910.14 12.82.1 55 (40–73) 18.3 (4.4–32.2) 0.05 1.3
Retinol-binding protein (free) RBP 21 0.380.057 21.43.6 85 (68–93) 13.6 (5.1–22.1) 0.017 5.8
Thyroid-stimulating hormone TSH 28 0.0670.017 1.460.35 2.4 (0.8–3.7) 0.99 (0.3–1.68) 0.05 2
	1-microglobulin 	1m 31 0.0920.013 324.6 38 (29–48) 21.2 (9.5–32.9) 2 32
	1-acid glycoprotein 	1AG 40 4.50.62  104 3.750.51 — — 0.2 770
Zinc-	2-globulin ZAG 41 1.650.24  103 2.590.38 — — 0.2 140
2-glycoprotein I 2GI 50 5.20.85  103 8.51.4 48 (37–56) 12.3 (6.1–18.5) 0.03 150
Vitamin D binding protein DBP 51.3 2.00.55  104 0.660.17 — — 0.1 400
Transthryetin TTR 55 2.10.34  104 0.680.11 — — 0.1 300
Albumin ALB 65.5 7.70.9  105 384.4 40 (19–52) 13.8 (6.6–21) 2.5 45000
Transferrin TRF 78 5.01.6  105 1.450.47 6.8 (1.9–15.5) 1.2 (0.6–1.8) 0.19 2700
Immunoglobulin G IgG 160 4.20.28  105 5.50.36 6.1 (2.6–8.1) 5.0 (4.4–5.6) 0.2 12000
Creatinine clearancec mL/min 83 (60–101) 33 (26–37) 58 (34–82)
Data are mean  SEM. Hyphens denote not measured.
a Normal plasma levels were obtained from the following literature sources:- 2m and TSH, (Abbott IMx and AxSym datasheets); free RBP, [22]; 	1m, [37];
	1AG, TTR, albumin, TRF and IgG, [26]; ZAG, [38]; 2GI, [39]; DBP, [40]
b Except TSH, mIU/L
c Mean (range)
to 15% polyacrylamide gels (Bio-Rad, Hemel Hemp- with GFR45 mL/min (data not shown). Impaired GFR
and associated glomerular disease was therefore unlikelystead, UK), proteins were transferred to polyvinylidene
to affect excretion of protein by the patients with Dent’sdifluoride (PVDF) membranes. Membranes were blocked
disease shown in Table 1. Protein excretion by threewith 3% albumin and probed with anti-human gamma
patients with Lowe’s syndrome and two patients withchain F(ab
)2 conjugated to horseradish peroxidase (HRP;
ADIF was similar to those with Dent’s disease, exceptSigma, Poole, UK; Cat. No. A2290), diluted 1:60,000 in
that excretion of LMW proteins by patients with Lowe’s0.1% bovine serum albumin (BSA), 500 mmol/L sodium
syndrome was even greater (Table 1).chloride, 0.1% Tween 20, in 20 mmol/L Tris, pH 7.5, and
visualized with ECL reagent (Amersham Pharmacia,
Calculation of glomerular sieving coefficientsMilton Keynes, UK).
Assuming that glomerular filtration is the only source
of a protein in the urine of a patient with a Fanconi
RESULTS syndrome and that there are no losses from, or additions
Measurements of protein excretion in random urine to, the filtrate, the glomerular filtrate concentration (GFC)
samples obtained from five affected male patients with of the protein is given by:
Dent’s disease are shown in Table 1. The five patients
GFC (mg/L)chosen for study were early in the course of their disease
with relatively preserved glomerular filtration rates (GFR;

(24-hour protein excretion, mg)
(24-hour volume of glomerular filtrate, L)
(Eq. 1)mean 83 mL/min, range 60 to 101). The results demon-
strate greatly elevated excretion of proteins ranging in
Random urine samples were used for measurementsmolecular weight from 11.6 to 160 kD. Increased excre-
of protein excretion to minimize the effects of proteintion of IgG measured by ELISA was confirmed by immu-
instability in urine and these are expressed as mg/mmolnoblotting, which showed that all material reacting with
creatinine (Table 1). The 24-hour excretion for individ-anti-Ig- antibody had the mobility expected of intact
ual proteins was then calculated based on the 24-hourIg on nonreducing SDS electrophoresis.
creatinine excretion by each patient. The 24-hour volumeThe excretion of both albumin and 	-1-microglobulin
of glomerular filtrate was calculated as the 24-hour creat-were evaluated in the five affected male patients with
inine clearance. When these measurements are substi-Dent’s disease and relatively preserved glomerular fil-
tuted into equation 1, this becomes:tration rates and three other Dent’s patients with im-
paired GFR. There was no relationship between the GFC (mg/L)
amount of either protein excreted and GFR for the five
patients in this group with GFR 45 mL/min. However,
increased excretion, not exceeding 2.6-fold, of either one 
protein excretion,mg/mmol   
24-hour creatinine
excretion, mmol 
(24-hour creatinine clearance, L)
(Eq. 2)
or both these proteins was present in the three patients
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Fig. 1. Estimated glomerular sieving coefficients for 12 plasma proteins versus molecular weight. Data are from Table 1; mean ( SEM) of five
determinations based on results from each of five patients with Dent’s disease are shown. See Molecular size, charge and glomerular sieving for
discussion of the anomalous behavior of 	1-acid glycoprotein (	1AG) and 2-glycoprotein-I (2GI). Abbreviations are: RBP, retinol-binding protein;
	2m, 	2-microglobulin; TSH, thyroid-stimulating hormone; ZAG, zinc-	2-globulin; DBP, vitamin D-binding protein; TTR, transthyretin; ALB,
albumin; TRF, transferrin; IgG, immunoglobulin G.
Then, by definition [2], we calculated: low, we looked for any effect of the analysis medium
(urine vs. serum) on assay results. The apparent hormone
The glomerular sieving coefficient, GSC
levels were measured in the following mixtures using
varying proportions of each component: serum and nor-

GFC
Plasma protein concentration
(Eq. 3) mal urine; serum and urine samples with high apparent
levels of endogenous hormones and normal urine and
Any errors introduced by these assumptions are con- urine samples with high apparent levels of endogenous
sidered in the Discussion section. The glomerular sieving hormone. This showed both over-recovery and under-
coefficients (GSCs) were estimated using the above recovery of up to 35% (IGF-1 and PTH, respectively)
model in the five patients with Dent’s disease (Table 1), although generally not exceeding 20% (data not shown).
and Figure 1 shows the estimated GSC plotted against Results in Table 2 are presented without adjustment for
the molecular weight of each protein. Kappa and lambda this apparent over-recovery and under-recovery. Insulin
immunoglobulin light chains, sex-hormone binding glob- was measured by two assays based on different technolo-
ulin and lysozyme could not be measured accurately in gies and antibodies with almost identical results; mea-
urine, either because of calibration bias or poor preci- surements using the DELFIA method only are given.
sion. Nevertheless, these four proteins were also present
in at least tenfold increased concentrations over normal
DISCUSSIONvalues (data not shown).
When hormone and chemokine excretion were mea- Our results for the 12 proteins shown in Table 1 show
sured (Table 2 and Fig. 2), greatly increased levels were that the excretion of most proteins involved in tubular
found including those of several potentially bioactive proteinuria is largely a function of plasma concentration
proteins. Since the absolute concentrations of the hor- and molecular size (Fig. 1). These measurements permit
the first estimates of the in vivo GSCs in humans andmones measured (Table 2) and of TSH (Table 1) were
Fig. 2. Hormone and chemokine excretion in urine of patients with Dent’s disease (); Lowe’s syndrome (); autosomal-dominant idiopathic
Fanconi syndrome (ADIF) (), and normal individuals (). Data are from Table 2. Excretion, in the following units, is expressed per mmol
creatinine: parathyroid hormone, ng; insulin, pmol; IGF-1, nmol; prolactin, mIU; growth hormone, mIU; luteinizing hormone, mIU and MCP-1, ng.
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Table 2. Hormone and chemokine excretion in the urine of patients with Dent’s disease, Lowe’s syndrome and
autosomal-dominant idiopathic Fanconi syndrome (ADIF)
Urinary excretion mIU/mmol creatinine c
Molecular
weight Dent’sa Lowe’sb ADIFb Normala
Hormones and MCP-1 kD N  5 N  3 N  2 N  8
Parathyroid hormone PTH 9.4 22.216.5 19.3 (10.7–24.1) 38 (18.8–57.6) 0.470.2 ng/mmol
Insulin INS 5.1 325116 545 (150–1202) 410 (195–625) 5.81.6 pmol/mmol
Insulin-like growth factor 1 IGF-1 15d 1.20.4 2.1 (1.8–2.4) 0.6 (0.15–1.08) 0.0110.002 nmol/mmol
Prolactin PRL 23 586139 1360 (909–1719) 207 (90–324) 6
Growth hormone GH 22 15.911.7 7.2 (5.7–10.0) 3.5 (2.9–4.1) 0.03
Luteinizing hormone LH 30 3.60.9 17.5 (10.7–25.6) 2.2 (1.7–2.7) 0.5
Monocyte chemoattractant protein 1 MCP-1 14 22364e 358 (185–510) 120 (68–171) 12.71.2 ng/mmolf
a MeanSEM
b Mean (range)
c Except insulin, IGF-1, PTH and MCP-1
d Bound to IGF-BP3
e N  4
f N  7
cover almost a 105-fold range. The additional data of of the low molecular weight proteins 2m and RBP in
the unselected patients with Lowe’s syndrome may beTable 2 and Figure 2 shows that several proteins of po-
tentially high bioactivity are excreted in high concentra- related to lower glomerular filtration in these (Table 1),
compared with the Dent’s patients who were chosention in the urine of patients with tubular proteinuria
and, by implication, are present in tubular fluids at high for study because of relatively preserved GFR. Indeed,
increased RBP excretion is found in patients with a vari-concentration.
ety of tubular and non-tubular diseases when GFR is
Calculation of glomerular sieving coefficients reduced by more than 70% [22]. The approach used in
Table 1 to estimate GSC cannot be used for the hor-Several assumptions are made in the calculation of
mones and chemokines shown in Table 2, because of thethe GSCs and errors in these will affect the final results
wide physiological fluctuations in their plasma levels.differently. The effect of instability of proteins in urine
was minimized by the use of rapidly processed random
Comparison between human and animal resultsurine specimens. Conversely, any impact of disease on
glomerular permeability might be expected to increase Measurements of the glomerular filtrate concentration
of albumin by micropuncture in rats and dogs havethe estimated GSC, at least for less freely filtered mole-
cules. No evidence was found for further increases in yielded a range from 1 to 50 mg/L. The reasons for
this variability have been discussed in detail [2]. Thethe excretion of 	1m and albumin until the creatinine
approach here, using equation 2 (Results section), givesclearance of patients with Dent’s disease fell to45 mL/
a value of 3.5  0.41 mg/L (536.4 nmol/L) in humans,min; measurements were specifically made early in the
for this important pathophysiological measurement.progression of renal impairment. Residual tubular pro-
There is controversy about the contribution of transcel-tein uptake in Dent’s disease, that is, an incomplete
lular reabsorption to retrieve albumin from the glomeru-knock-out of tubular protein reabsorption, cannot be
lar filtrate [23–25]. It is not known how the molecularwholly excluded because the exact pathway(s) have not
defect in the syndromes we have studied might affectbeen defined. However the results for 2m demonstrated
any transcellular reabsorption, and some residual tubulara recovery in urine of 91  14% of all 2m filtered by
reabsorption would mean an underestimation of the re-the glomerulus; recovery is calculated as (GFC/plasma
ported albumin GSC here. Nevertheless, even a twofoldprotein concentration) where GFC is found from equa-
underestimate of true albumin filtration predicts a glo-tion 2 in the Results section using the data from Table
merular fluid concentration of albumin of only 7.0 mg/L1. Since 2m is probably freely filtered [2], this finding
(106 nmol/L), which is still toward the lower end of thatsuggests that most tubular reuptake, at least for this
determined by invasive animal studies.protein, is disrupted; given the known instability of this
protein in urine, the true recovery of 2m is probably
Molecular size, charge, and glomerular sievingeven higher [3]. The three diseases of diverse molecular
pathology all appear to show similar increases in the Not unexpectedly, Figure 1 shows several deviations
from a monotonic curve. Excretion of 	1-acid glycopro-excretion of each protein (Table 1) and therefore the
simplest explanation is that there is a common loss of tein and 2-glycoprotein I appear anomalously low and
high respectively (Fig. 1). Alpha1-acid glycoprotein hasfunction of a single final pathway. The higher excretion
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an unusually low isoelectric point, pI  2.7, [26] whereas propriately elevated serum 1,25(OH)2-vitamin D levels
leading to enhanced intestinal calcium absorption andin contrast the pI of 2GI is unusually high, pI  6.4 to
8.2 for nine major isoforms in urine [4, 5]. The isoelectric thus explaining the hypercalciuria of Dent’s disease [13].
Elevated urinary PTH levels have also recently beenpoints of most of the other proteins studied, except for
IgG, are all in the range from about 4.0 to 6.0 [26]. An reported in a mouse model of Dent’s disease [13]. It is
notable that the levels we have found in the urine ofeffect of extremes of charge on GSC is therefore appar-
ent for those proteins with GSCs that neither approach patients with Dent’s disease, expressed as a multiple of
normal, are frequently higher than those reported in thatone nor are very low (Table 1 and Fig. 1). This is consis-
tent with studies of the glomerular filtration of dextrans mouse model (Table 2).
Monocyte chemoattractant protein-1 in tubular fluidin humans, which suggest that fixed, negatively charged
components of the capillary wall relatively hinder filtra- may promote tubulointerstitial fibrosis [36] and the po-
tential tubular fluid concentrations calculated from thetion of more negatively charged proteins [27]. Tables 1
and 2 show that before development of marked renal results of Table 1 are well within the range of those
known to have biological activity. Increased urinaryfailure, the commonly used LMW protein markers (2m,
RBP, and 	1m) account for about one half of the protein- MCP-1 is found in patients with active renal vasculitis
and persistence of this increase is associated with pro-uria in the Fanconi syndrome, albumin for some 30%
and the remainder comprises a diverse group of proteins. gression to end-stage renal failure (abstract; Tam, J Am
Soc Nephrol 11:99A, 2000). The relative contributions
Implications for specificity of the endocytic pathway of any local renal production and glomerular filtration
to the amount excreted in these conditions are unclear.Receptor-mediated endocytosis is believed to underlie
protein transport from the proximal tubular lumen and An important role for MCP-1 in macrophage-mediated
tubular injury role has been found by the study micedefects of this pathway have been studied in Dent’s dis-
ease [abstract; Norden et al, J Am Soc Nephrol (in press)] deficient in this chemokine [36]. Similarly, bioactive
IGF-1, which has been shown by micropuncture studies[13, 14]. The exact structure of the receptor(s) is unclear,
although both megalin and cubilin are almost certainly to occur in the tubular fluids of nephrotic rats [34], might
contribute to the tubulointerstitial lesions of patientsinvolved [13, 14, 28–31]. In vitro receptor-binding studies
of a variety of proteins to megalin and cubilin are entirely with the renal Fanconi syndrome.
Progressive renal failure has been described as a fea-consistent with our results (abstract; Christensen, J Am
Soc Nephrol 11:49A, 2000) [4, 28, 30, 32, 33]. However, ture of most forms of the Fanconi syndrome [6, 7]. The
explanation for this renal failure may lie in progressivethe putative receptor(s) for several important potential
ligands described here, remain to be identified: These tubular and interstitial damage caused by the high levels
of potentially bioactive hormones and MCP-1 identifiedinclude thyroid-stimulating hormone, immunoglobulin
G and monocyte chemoattractant protein-1. Although (Table 2 and Fig. 2).
Our findings provide a unifying quantitative explana-our findings do not delineate which pathways are defec-
tive in Dent’s disease, they suggest that the normal endo- tion for the excretion of large amounts of higher molecu-
lar weight proteins in addition to the more freely filteredcytic pathway can process an even wider array of ligands
than described so far. LMW proteins in patients with the renal Fanconi syn-
drome. Results of glomerular sieving coefficients esti-
Pathophysiological role of tubular fluid mated here are both self-consistent (Table 1 and Fig. 1)
and consistent with much animal work. Further molecu-Progressive renal failure is a very common feature of
the Fanconi syndrome [6, 7]. There is evidence from lar studies are needed to account for the versatility and
efficiency of the proximal tubular endocytic uptake sys-animal studies that bioactivity of tubular fluid may con-
tribute to the progression of renal disease [34], and our tem and to assess the pathophysiological consequences
of the probable high hormone and chemokine contentresults demonstrate that a number of potentially bioac-
tive proteins are excreted in large amounts by patients of tubular fluids in the Fanconi syndrome.
with Dent’s disease, Lowe’s syndrome, and ADIF. The
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